These authors contributed equally to the manuscript.
Genetic variation in the interleukin-28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection†
Article first published online: 19 AUG 2011
Copyright © 2011 American Association for the Study of Liver Diseases
Volume 54, Issue 4, pages 1127–1134, October 2011
How to Cite
Marabita, F., Aghemo, A., De Nicola, S., Rumi, M. G., Cheroni, C., Scavelli, R., Crimi, M., Soffredini, R., Abrignani, S., De Francesco, R. and Colombo, M. (2011), Genetic variation in the interleukin-28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection. Hepatology, 54: 1127–1134. doi: 10.1002/hep.24503
Potential conflict of interest : Dr. Rumi received grants from Roche, Janssen, and Gilead. Dr. Colombo advises and received grants from Roche, Merck, Gilead, Bayers, and Bristol-Myers Squibb. He also advises Tibotec.
- Issue published online: 27 SEP 2011
- Article first published online: 19 AUG 2011
- Accepted manuscript online: 30 JUN 2011 07:11PM EST
- Manuscript Accepted: 7 JUN 2011
- Manuscript Received: 18 FEB 2011
Additional Supporting Information may be found in the online version of this article.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.